Page last updated: 2024-08-18

cyclohexanol and Cardiovascular Diseases

cyclohexanol has been researched along with Cardiovascular Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P1
Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S1
Archer, DF; Cheng, RF; Guico-Pabia, CJ; Hwang, E; Pinkerton, JV1
Begley, AE; Johnson, EM; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E; Whyte, E1
Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B1

Reviews

1 review(s) available for cyclohexanol and Cardiovascular Diseases

ArticleYear
Novel antidepressant drugs, arterial hypertension and cardiovascular disease.
    Recent patents on cardiovascular drug discovery, 2013, Volume: 8, Issue:3

    Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2013

Trials

2 trial(s) available for cyclohexanol and Cardiovascular Diseases

ArticleYear
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
    Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1

    Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Risk Factors; Treatment Outcome

2013
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:9

    Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride

2006

Other Studies

3 other study(ies) available for cyclohexanol and Cardiovascular Diseases

ArticleYear
Treatment with duloxetine in adults and the incidence of cardiovascular events.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult

2012
Venlafaxine and cardiac effects.
    Prescrire international, 2005, Volume: 14, Issue:78

    Topics: Antidepressive Agents; Cardiovascular Diseases; Cyclohexanols; Humans; United Kingdom

2005
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
    International journal of psychiatry in medicine, 1997, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride

1997